Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension

Author(s):
Papapoulos, S.; Chapurlat, R.; Libanati, C.; Brandi, M.L.; Brown, J.P.; Czerwinski, E.; Krieg, M.A.; Man, Z.; Mellstrom, D.; Radominski, S.C.; Reginster, J.Y.; Resch, H.; Ivorra, J.A.R.; Roux, C.; Vittinghoff, E.; Austin, M.; Daizadeh, N.; Bradley, M.N.; Grauer, A.; Cummings, S.R.; Bone, H.G.
Published
2012
Publication type
Article / Letter to editor
BONE MINERAL DENSITYBONE TURNOVER MARKERSDENOSUMABFRACTUREPIVOTAL FRACTURE TRIAL EXTENSION
Date issued
2012-03-31
Language
English
Is part of
hdl
1887/98753
doi
10.1002/jbmr.1479